Sir Mene Pangalos, executive vice president, BioPharmaceuticals R&D, AstraZeneca, has stressed the importance of a new collaboration and licensing agreement to 16 June 2023
Verve Therapeutics is a clinical-stage genetic medicines company that claims to be pioneering a new approach to the care of cardiovascular disease. 16 June 2023
The preeminent role of Farxiga (dapagliflozin) in heart failure (HF) has been given a boost by new long-term data presented at the annual meeting of the Europea 23 May 2023
Much has been made of the sudden rise in sales of Wegovy (semaglutide) and the weight loss drug’s impact in driving rapid growth at Novo Nordisk. 16 May 2023
German life sciences company Bayer was trading 7% lower in mid-afternoon trading on Thursday after presenting its first-quarter financial results and latest out 11 May 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.